The multiple myeloma market is becoming increasingly important as oncologists and healthcare systems focus on earlier diagnosis, individualized treatment sequencing, and improved long-term disease management. Treatment approaches support demanding applications across newly diagnosed, relapsed, and refractory patient populations. The growing emphasis on targeted therapies, immunotherapy...